{"DataElement":{"publicId":"6762852","version":"1","preferredName":"Acute Lymphoblastic Leukemia National Cancer Institute Risk Group At First Diagnosis NCI Acute Lymphoblastic Leukemia Risk Group Type","preferredDefinition":"The NCI risk group assigned to a patient at initial diagnosis with Acute Lymphoblastic Leukemia.","longName":"NCI_ALL_RK_GP_DX_TP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6762848","version":"1","preferredName":"Acute Lymphoblastic Leukemia National Cancer Institute Risk Group At First Diagnosis","preferredDefinition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia._The National Cancer Institute, part of the National Institutes of Health of the United States Department of Health and Human Services, is the Federal Government's principal agency for cancer research. The National Cancer Institute conducts, coordinates, and funds cancer research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer. Access the National Cancer Institute Web site at http://www.cancer.gov._The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable._Any number of entities (members) considered as a unit._Used to indicate position, location, or state._Preceding all others in time or space or degree._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"2674126v1.0:6762846v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2674126","version":"1","preferredName":"ALL","preferredDefinition":"A leukemia with an acute onset, characterized by the presence of lymphoblasts or Burkitt cells in the bone marrow and the peripheral blood.  It includes the precursor B lymphoblastic leukemia, precursor T lymphoblastic leukemia, and Burkitt's leukemia.","longName":"C3167","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3834F55C-324A-1EBE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-21","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-21","modifiedBy":"ONEDATA","dateModified":"2007-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6762846","version":"1","preferredName":"National Cancer Institute Risk Group At First Diagnosis","preferredDefinition":"The National Cancer Institute, part of the National Institutes of Health of the United States Department of Health and Human Services, is the Federal Government's principal agency for cancer research. The National Cancer Institute conducts, coordinates, and funds cancer research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer. Access the National Cancer Institute Web site at http://www.cancer.gov.:The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.:Any number of entities (members) considered as a unit.:Used to indicate position, location, or state.:Preceding all others in time or space or degree.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"6762846v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Cancer Institute","conceptCode":"C19202","definition":"The Federal Government's principal agency for cancer research. NCI conducts, coordinates, and funds cancer research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer. Part of the National Institutes of Health of the United States Department of Health and Human Services.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Group","conceptCode":"C43359","definition":"Any number of entities (members) considered as a unit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"At","conceptCode":"C25427","definition":"Used to indicate position, location, or state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"891AB3E5-94C7-47F7-E053-F662850A4A4D","latestVersionIndicator":"Yes","beginDate":"2019-05-17","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-17","modifiedBy":"ONEDATA","dateModified":"2019-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"891AB3E5-94D8-47F7-E053-F662850A4A4D","latestVersionIndicator":"Yes","beginDate":"2019-05-17","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-17","modifiedBy":"SETRAKIN","dateModified":"2019-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6762849","version":"1","preferredName":"NCI Acute Lymphoblastic Leukemia Risk Group Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6762849v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"NCI High Risk","valueDescription":"High Risk Acute Leukemia","ValueMeaning":{"publicId":"6767168","version":"1","preferredName":"High Risk Acute Leukemia","longName":"6767168","preferredDefinition":"Acute leukemia patients are stratified into the high risk group when their minimal residual disease levels are higher than 0.05%.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Risk Acute Leukemia","conceptCode":"C122458","definition":"Acute leukemia patients are stratified into the high risk group when their minimal residual disease levels are higher than 0.05%.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8994F07D-65A8-2C6A-E053-F662850AA799","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8994F07D-65C1-2C6A-E053-F662850AA799","beginDate":"2019-05-17","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"NCI Standard Risk","valueDescription":"Standard Risk Acute Leukemia","ValueMeaning":{"publicId":"6767169","version":"1","preferredName":"Standard Risk Acute Leukemia","longName":"6767169","preferredDefinition":"Acute leukemia patients are stratified into the standard risk group when their minimal residual disease levels are lower than 0.05%.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Standard Risk Acute Leukemia","conceptCode":"C122457","definition":"Acute leukemia patients are stratified into the standard risk group when their minimal residual disease levels are lower than 0.05%.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8994F07D-65CD-2C6A-E053-F662850AA799","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8994F07D-65E6-2C6A-E053-F662850AA799","beginDate":"2019-05-17","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"891A51E1-53CA-1132-E053-F662850AD7E2","latestVersionIndicator":"Yes","beginDate":"2019-05-17","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-17","modifiedBy":"SETRAKIN","dateModified":"2019-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"NCI Risk Group at initial dia","type":"Preferred Question Text","description":"NCI Risk Group at initial diagnosis:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"891AB3E5-94F3-47F7-E053-F662850A4A4D","latestVersionIndicator":"Yes","beginDate":"2019-05-17","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-17","modifiedBy":"SETRAKIN","dateModified":"2019-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}